Skip to main content
. 2019 Jun 5;14(6):e0217778. doi: 10.1371/journal.pone.0217778

Fig 3. Tornado diagram of one-way sensitivity analyses for the 40–49 age group and lifetime horizon of the TH vs. NT arm.

Fig 3

Abbreviations: ICER, incremental cost-effectiveness ratio; NT, no adjuvant trastuzumab; TH, adjuvant paclitaxel and trastuzumab regimen.